Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2

Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.

Guardado en:
Detalles Bibliográficos
Autores principales: Reiter, Russel J., Cardinali, Daniel Pedro, Neel, Richard L., Domínguez Rodriguez, Alberto, Brown, Gregory M., Tesarik, Jan
Formato: Artículo
Lenguaje:Inglés
Publicado: ST-Bio-Life LLC 2022
Materias:
MELATONINA
SARS-CoV-19
VARIANTE DELTA COVID-19
VARIANTES FUTURAS
Acceso en línea:https://repositorio.uca.edu.ar/handle/123456789/13671
Aporte de:
Repositorio Institucional de la Universidad Católica Argentina (UCA) de Universidad Católica Argentina
Descripción
Sumario:Abstract: Melatonin was shown to prevent or mitigate a number of different respiratory and nonrespiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.

Ejemplares similares